MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy

SIMPLE SUMMARY: In order to compare responses to different therapies among clinical trials and to differentiate between therapy-induced changes and true tumor progression, reliable response parameters are crucial. With the advent of targeted and immunologic treatments, several assessment tools have...

Descripción completa

Detalles Bibliográficos
Autores principales: Heugenhauser, Johanna, Galijasevic, Malik, Mangesius, Stephanie, Goebel, Georg, Buchroithner, Johanna, Erhart, Friedrich, Pichler, Josef, Widhalm, Georg, Stockhammer, Günther, Iglseder, Sarah, Freyschlag, Christian F., Oberndorfer, Stefan, Bordihn, Karin, von Campe, Gord, Czech, Thomas, Surböck, Birgit, Urbanic Purkart, Tadeja, Marosi, Christine, Felzmann, Thomas, Nowosielski, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946797/
https://www.ncbi.nlm.nih.gov/pubmed/35326730
http://dx.doi.org/10.3390/cancers14061579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946797/
https://www.ncbi.nlm.nih.gov/pubmed/35326730
http://dx.doi.org/10.3390/cancers14061579

Ejemplares similares